DE60036790D1 - Verwendung von e5564 zur behandlung von sepsis durch intravenöse infusion - Google Patents

Verwendung von e5564 zur behandlung von sepsis durch intravenöse infusion

Info

Publication number
DE60036790D1
DE60036790D1 DE60036790T DE60036790T DE60036790D1 DE 60036790 D1 DE60036790 D1 DE 60036790D1 DE 60036790 T DE60036790 T DE 60036790T DE 60036790 T DE60036790 T DE 60036790T DE 60036790 D1 DE60036790 D1 DE 60036790D1
Authority
DE
Germany
Prior art keywords
sepsis
intravenous infusion
treatment
methods
endotoxemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60036790T
Other languages
English (en)
Other versions
DE60036790T2 (de
Inventor
Daniel P Rossignol
Melvyn Lynn
William D Kerns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Publication of DE60036790D1 publication Critical patent/DE60036790D1/de
Application granted granted Critical
Publication of DE60036790T2 publication Critical patent/DE60036790T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60036790T 1999-01-14 2000-01-14 Verwendung von e5564 zur behandlung von sepsis durch intravenöse infusion Expired - Lifetime DE60036790T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11620299P 1999-01-14 1999-01-14
US116202P 1999-01-14
PCT/US2000/001043 WO2000041703A1 (en) 1999-01-14 2000-01-14 Administration of an anti-endotoxin drug by intravenous infusion

Publications (2)

Publication Number Publication Date
DE60036790D1 true DE60036790D1 (de) 2007-11-29
DE60036790T2 DE60036790T2 (de) 2008-07-24

Family

ID=22365882

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60045750T Expired - Lifetime DE60045750D1 (de) 1999-01-14 2000-01-14 E5564 zur Verwendung in der Behandlung von Allograft-Abstossung oder Host-versus-Graft-Erkrankungen
DE60036790T Expired - Lifetime DE60036790T2 (de) 1999-01-14 2000-01-14 Verwendung von e5564 zur behandlung von sepsis durch intravenöse infusion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60045750T Expired - Lifetime DE60045750D1 (de) 1999-01-14 2000-01-14 E5564 zur Verwendung in der Behandlung von Allograft-Abstossung oder Host-versus-Graft-Erkrankungen

Country Status (11)

Country Link
EP (3) EP1867336B1 (de)
JP (1) JP2002534471A (de)
AT (2) ATE375798T1 (de)
AU (1) AU2614400A (de)
CA (1) CA2359478A1 (de)
CY (1) CY1108039T1 (de)
DE (2) DE60045750D1 (de)
DK (1) DK1158990T3 (de)
ES (1) ES2291188T3 (de)
PT (1) PT1158990E (de)
WO (1) WO2000041703A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004503472A (ja) * 2000-06-09 2004-02-05 エーザイ株式会社 ボーラスまたは間欠的な静脈内注入による、抗内毒素薬の投与
US20030105033A1 (en) 2000-06-09 2003-06-05 Rossignol Daniel P. Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
WO2003013440A2 (en) * 2001-08-10 2003-02-20 Eisai Co., Ltd. Treatment and prevention of heat shock protein-associated diseases and conditions
JP6778681B2 (ja) 2014-12-12 2020-11-04 ザ ファインスタイン インスティテュート フォー メディカル リサーチ Ｈｍｇｂ１媒介性炎症の治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530113A (en) 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US5750664A (en) * 1995-06-05 1998-05-12 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia

Also Published As

Publication number Publication date
EP2298326A3 (de) 2011-04-27
DE60045750D1 (de) 2011-04-28
ATE501760T1 (de) 2011-04-15
EP1867336A2 (de) 2007-12-19
WO2000041703A1 (en) 2000-07-20
JP2002534471A (ja) 2002-10-15
EP1867336A3 (de) 2008-04-23
ES2291188T3 (es) 2008-03-01
CA2359478A1 (en) 2000-07-20
EP2298326A2 (de) 2011-03-23
EP1158990A4 (de) 2003-08-13
DE60036790T2 (de) 2008-07-24
DK1158990T3 (da) 2008-01-28
ATE375798T1 (de) 2007-11-15
EP1867336B1 (de) 2011-03-16
EP1158990A1 (de) 2001-12-05
EP1158990B1 (de) 2007-10-17
CY1108039T1 (el) 2013-09-04
AU2614400A (en) 2000-08-01
PT1158990E (pt) 2007-12-21

Similar Documents

Publication Publication Date Title
ATE246197T1 (de) Neue heteroaromatische fructose 1,6- bisphosphatase inhibitoren
FR12C0004I1 (de)
DE60239612D1 (de) Monodisperse mischungen und verfahren zur behandlung von diabetes
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE69206341D1 (de) Verfahren zur Behandlung von BCTMP/CTMP-Abwasser.
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
ATE350385T1 (de) Neue aryl fructose-1,6-bisphosphatase inhibitoren
ATE253063T1 (de) 5-ht1f-agonisten
CY1109817T1 (el) Ολιγο-βητα-(1,3)-γλυκανη και μονοκλωνικα αντισωματα εναντιον καρκινου
ATE199321T1 (de) Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen.
CY1108039T1 (el) Χρηση e5564 για την θεραπεια σηψαιμιας με ενδοφλεβια εγχυση
ATE312104T1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
ATE517617T1 (de) Behandlung von parkinson erkrankung mit kape
WO2001093921A3 (en) Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
DE60020729D1 (de) Verfahren und zusammensetzung zur behandlung von adenovirale augeninfektionen
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
ATE335504T1 (de) Humanisierte antikörper zur erkennung von verotoxin ii sowie zellinie zur herstellung derselben
EA199800822A1 (ru) Способ лечения избыточной агрессии
DE60110468D1 (de) Chemische verbindungen
ATE439136T1 (de) Verfahren zur behandlung von halitose
SE9702993D0 (sv) Anti-mikrobial komposition
UA30956A (uk) Спосіб лікування алергічного риніту
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств

Legal Events

Date Code Title Description
8364 No opposition during term of opposition